Fulcrum Therapeutics financial statements

풀크럼 테라퓨틱스NASDAQ:FULC · Nasdaq · Healthcare · sector #13
$3.71+0.54%
2026-10-05 close

Fulcrum Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $80M. 2024 operating profit was −$22M.

Reported results

Fulcrum Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q